ILAE-North America
The current ILAE-North America region was constituted in 2006, comprising English speaking North American Chapters of Canada, the United States of America, and the English speaking Caribbean (represented by Jamaica). The Mexican chapter, although geographically in North America, is a member of the Latin American Regional Commission.
Our goals and aims are aligned with the ILAE’s emphasis on current and emerging knowledge on epilepsy prevention, diagnosis, treatment, research, and optimal comprehensive epilepsy care.
NEW! Global Health in Epilepsy Project Database
The Global Health Task Force has just launched an initiative to identify and connect international projects aimed at reducing the global epilepsy treatment gap, and it is now accepting ongoing, completed, and upcoming projects.
The goals are to increase collaboration, amplify impact, reduce redundancy, engage possible funders, and identify service opportunities.
Latest News
World News
Call for applications for research grants
Applications are now being accepted for funds for a two year research project aimed at understanding the pathogenesis of Dravet syndrome and paving the way to new treatments.
19 January, 2021
Clinical Research
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
This article examines the potential impact of FUS (Focused ultrasound) on the landscape of brain therapies as well as the challenges facing further advancement and broader adoption of this promising minimally invasive therapeutic alternative.
7 January, 2021
World News
50 Million Steps for Epilepsy
From Monday, January 4th to International Epilepsy Day – Monday February 8th, the International Bureau for Epilepsy encourages everyone to walk to raise awareness, improve visibility, and to increase understanding of epilepsy.
4 January, 2021
Clinical Research
Impact of predictive, preventive and precision medicine strategies in epilepsy
The anti-seizure medications used to treat patients with epilepsy can improve symptoms but do not address the underlying cause of the condition. In this Review, the authors discuss the ongoing shift towards personalized treatments for specific epilepsy aetiologies.
1 December, 2020
Clinical Research
Pharmacologic treatment and SUDEP risk
These results provide support for the importance of medication adherence and intensified AED treatment for patients with poorly controlled GTCS in the effort to reduce SUDEP risk and suggest that comedication with statins may reduce risk.
4 November, 2020
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community